Literature DB >> 6851098

Liquid-chromatographic study of fluorescent materials in uremic fluids.

J S Swan, E Y Kragten, H Veening.   

Abstract

Using reversed-phase "high-performance" liquid chromatography with fluorescence detection, we separated and identified some naturally fluorescent compounds in uremic serum and hemodialysate from patients with chronic renal disease. Several of the naturally fluorescent compounds were identified as indole derivatives by co-chromatography with authentic standards. In one specific case, the identity was confirmed by an enzymic peak-shift method. Compounds identified included indican, kynurenic acid, tryptophan, and 5-hydroxy-indole-3-acetic acid. Comparison of normal and uremic serum showed that the fluorescent materials are present in significantly greater concentrations in samples from uremic patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851098

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.

Authors:  D Pawlak; K Pawlak; J Malyszko; M Mysliwiec; W Buczko
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?

Authors:  Adrian Mor; Bartlomiej Kalaska; Dariusz Pawlak
Journal:  Int J Tryptophan Res       Date:  2020-09-21

3.  Transport of Kynurenic Acid by Rat Organic Anion Transporters rOAT1 and rOAT3: Species Difference between Human and Rat in OAT1.

Authors:  Yuichi Uwai; Hiroaki Hara; Kikuo Iwamoto
Journal:  Int J Tryptophan Res       Date:  2013-02-17

4.  Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?

Authors:  Jürgen Arund; Merike Luman; Fredrik Uhlin; Risto Tanner; Ivo Fridolin
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

5.  Increased urinary excretion of kynurenic acid is associated with non-recovery from acute kidney injury in critically ill patients.

Authors:  Fabienne Aregger; Dominik E Uehlinger; Gerhard Fusch; Aldin Bahonjic; Rene Pschowski; Michael Walter; Joerg C Schefold
Journal:  BMC Nephrol       Date:  2018-02-26       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.